Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

Fever and rash can be early signs of lupus.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Adults with certain skin conditions may have higher levels of inflammation in their body.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Alopecia areata involves immune response and gene changes affecting hair loss.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.